Squalene synthase
From Proteopedia
(Difference between revisions)
| Line 42: | Line 42: | ||
**[[3wcj]] – hSQS (mutant) + pyrrolidine derivative<br /> | **[[3wcj]] – hSQS (mutant) + pyrrolidine derivative<br /> | ||
**[[3wcm]] – hSQS (mutant) + pyridine derivative<br /> | **[[3wcm]] – hSQS (mutant) + pyridine derivative<br /> | ||
| - | **[[3wsa]] – hSQS (mutant) + tuberculosis drug<br /> | + | **[[3wsa]], [[3wsb]] – hSQS (mutant) + tuberculosis drug<br /> |
| + | **[[3wef]], [[3weg]] – hSQS + FPP analog <br /> | ||
| + | **[[3weh]] – hSQS + presqualene pyrophosphate <br /> | ||
| + | **[[3wei]], [[3wej]], [[3wek]] – hSQS (mutant) + presqualene pyrophosphate <br /> | ||
| + | **[[3wca]], [[3wcb]], [[3wcc]], [[3wce]], [[3wcg]] – SQS (mutant) + FPP analog – ''Trypanosoma cruzi''<br /> | ||
}} | }} | ||
Revision as of 09:56, 31 August 2016
| |||||||||||
3D structures of squalene synthase
Updated on 31-August-2016
References
- ↑ Tansey TR, Shechter I. Squalene synthase: structure and regulation. Prog Nucleic Acid Res Mol Biol. 2001;65:157-95. PMID:11008488
- ↑ Kourounakis AP, Katselou MG, Matralis AN, Ladopoulou EM, Bavavea E. Squalene synthase inhibitors: An update on the search for new antihyperlipidemic and antiatherosclerotic agents. Curr Med Chem. 2011;18(29):4418-39. PMID:21864285
- ↑ Shang N, Li Q, Ko TP, Chan HC, Li J, Zheng Y, Huang CH, Ren F, Chen CC, Zhu Z, Galizzi M, Li ZH, Rodrigues-Poveda CA, Gonzalez-Pacanowska D, Veiga-Santos P, de Carvalho TM, de Souza W, Urbina JA, Wang AH, Docampo R, Li K, Liu YL, Oldfield E, Guo RT. Squalene synthase as a target for Chagas disease therapeutics. PLoS Pathog. 2014 May 1;10(5):e1004114. doi: 10.1371/journal.ppat.1004114., eCollection 2014 May. PMID:24789335 doi:http://dx.doi.org/10.1371/journal.ppat.1004114
